<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04166058</url>
  </required_header>
  <id_info>
    <org_study_id>LIN-MD-66</org_study_id>
    <secondary_id>2019-001955-38</secondary_id>
    <nct_id>NCT04166058</nct_id>
  </id_info>
  <brief_title>Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C</brief_title>
  <official_title>A Phase 3, Open-label, Long-term Safety Study of Oral Linaclotide Administered to Pediatric Participants With Functional Constipation (FC) or Irritable Bowel Syndrome With Constipation (IBS-C)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ironwood Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      LIN-MD-66 is a Phase 3 open-label study with 24 weeks (Functional Constipation participants)&#xD;
      or 52 weeks (Irritable bowel syndrome with constipation participants) of linaclotide exposure&#xD;
      that will enroll pediatric participants (6-17 years of age) with FC or IBS-C who completed&#xD;
      study intervention in studies LIN-MD-62, LIN-MD-63, orLIN-MD-64 based on the individual study&#xD;
      criteria.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 19, 2019</start_date>
  <completion_date type="Anticipated">July 29, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 14, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Treatment Emergent Adverse Events</measure>
    <time_frame>24 to 52 weeks</time_frame>
    <description>Number of Participants With Treatment-Emergent Adverse Events (TEAEs).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Irritable Bowel Syndrome With Constipation</condition>
  <condition>Functional Constipation</condition>
  <arm_group>
    <arm_group_label>72 μg linaclotide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An oral capsule that is taken once daily. It may be taken whole or sprinkled into 1 teaspoonful of applesauce or 30mL of bottled water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>145 μg linaclotide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An oral capsule that is taken once daily. It may be taken whole or sprinkled into 1 teaspoonful of applesauce or 30mL of bottled water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>290 μg linaclotide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An oral capsule that is taken once daily. It may be taken whole or sprinkled into 1 teaspoonful of applesauce or 30mL of bottled water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers)</intervention_name>
    <description>Participants whom are between the ages of 7-11 years old at their time of enrollment will be assigned a dose (72 μg or 145 μg) based on their weight. Randomized doses (145 μg or 290 μg) will be assigned to participants whom are 12-17 years old at the time of enrollment.</description>
    <arm_group_label>145 μg linaclotide</arm_group_label>
    <arm_group_label>290 μg linaclotide</arm_group_label>
    <arm_group_label>72 μg linaclotide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)</intervention_name>
    <description>Participants whom are between the ages of 6-11 years old at their time of enrollment will be assigned a dose of 72 μg. Randomized doses (72 μg or 145 μg) will be assigned to participants whom are 12-17 years old at the time of enrollment.</description>
    <arm_group_label>145 μg linaclotide</arm_group_label>
    <arm_group_label>72 μg linaclotide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant weighs ≥ 18 kg at the time the parent/guardian/LAR and/or caregiver has&#xD;
             provided signed consent.&#xD;
&#xD;
          -  Female participants who have had their first menstrual period and are sexually active&#xD;
             must agree to use a reliable form of contraception.&#xD;
&#xD;
          -  Participants must have completed study intervention in their lead-in study.&#xD;
&#xD;
        Inclusion Criteria for Phase 2 LIN-MD-62 or Phase 2 LIN-MD-63 and Phase 3 LIN-MD-64&#xD;
        completers who enroll in LIN-MD-66 after &gt;28 days from last study intervention:&#xD;
&#xD;
          -  Female participants of childbearing potential must have a negative serum pregnancy&#xD;
             test at the Screening Visit (Visit 1) and negative urine pregnancy test prior to the&#xD;
             first dose on the Day 1 Visit (Visit 2).&#xD;
&#xD;
          -  LIN-MD-63 completers only: Participants meet Rome III criteria for child/adolescent&#xD;
             IBS: At least once per week for at least 2 months before the LIN-MD-66 Screening Visit&#xD;
             (Visit 1), the participant has experienced abdominal discomfort (an uncomfortable&#xD;
             sensation not described as pain) or pain associated with 2 or more of the following at&#xD;
             least 25% of the time:&#xD;
&#xD;
               -  a) Improvement with defecation&#xD;
&#xD;
               -  b) Onset associated with a change in frequency of stool&#xD;
&#xD;
               -  c) Onset associated with a change in form (appearance) of stool&#xD;
&#xD;
          -  Participants meet modified Rome III criteria for child/adolescent FC: For at least 2&#xD;
             months before the LIN-MD-66 Screening Visit (Visit 1), the participant has had 2 or&#xD;
             fewer defecations (with each defecation occurring in the absence of any laxative,&#xD;
             suppository, or enema use during the preceding 24 hours) in the toilet per week. In&#xD;
             addition, at least once per week, participant meets 1 or more of the following:&#xD;
&#xD;
               -  a) History of retentive posturing or excessive volitional stool retention&#xD;
&#xD;
               -  b) History of painful or hard BMs&#xD;
&#xD;
               -  c) Presence of a large fecal mass in the rectum&#xD;
&#xD;
               -  d) History of large diameter stools that may obstruct the toilet&#xD;
&#xD;
               -  e) At least 1 episode of fecal incontinence per week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant has a known allergy or sensitivity to the study intervention or its&#xD;
             components or other medications in the same drug class.&#xD;
&#xD;
          -  Participant received an investigational drug, other than linaclotide, during the 30&#xD;
             days before the Screening Visit (Visit 1) or is planning to receive an investigational&#xD;
             drug (other than that administered during this study) or use an investigational device&#xD;
             at any time during the study.&#xD;
&#xD;
          -  Female participants who are currently pregnant or nursing, or plan to become pregnant&#xD;
             or nurse during the clinical study.&#xD;
&#xD;
          -  Participant has required manual disimpaction any time prior to study intervention or&#xD;
             disimpaction during in-patient hospitalization within 1 year prior to study&#xD;
             intervention.&#xD;
&#xD;
          -  Participant has any of the following conditions:&#xD;
&#xD;
               -  a) Down's syndrome or any other chromosomal disorder&#xD;
&#xD;
               -  b) Anatomic malformations (eg, imperforate anus, anal stenosis, anterior&#xD;
                  displaced anus)&#xD;
&#xD;
               -  c) Intestinal nerve or muscle disorders (eg, Hirschprung disease, visceral&#xD;
                  myopathies, visceral neuropathies)&#xD;
&#xD;
               -  d) Neuropathic conditions (eg, spinal cord abnormalities, neurofibromatosis,&#xD;
                  tethered cord, spinal cord trauma)&#xD;
&#xD;
               -  e) Neurodevelopmental disabilities (early-onset, chronic disorders that share the&#xD;
                  essential feature of a predominant disturbance in the acquisition of cognitive,&#xD;
                  motor, language, or social skills, which has a significant and continuing impact&#xD;
                  on the developmental progress of an individual) producing a cognitive delay that&#xD;
                  precludes comprehension by the participant.&#xD;
&#xD;
          -  Participant has a mechanical bowel obstruction or pseudo-obstruction.&#xD;
&#xD;
          -  Participant currently has both unexplained and clinically significant alarm symptoms&#xD;
             (lower GI bleeding [rectal bleeding or heme-positive stool], iron-deficiency anemia,&#xD;
             or any unexplained anemia, or weight loss) and systemic signs of infection or colitis,&#xD;
             or any neoplastic process.&#xD;
&#xD;
          -  Participant has an active anal fissure (Note: history of anal fissure is not an&#xD;
             exclusion).&#xD;
&#xD;
          -  Participant has had surgery that meets any of the following criteria:&#xD;
&#xD;
               -  a) Bariatric surgery for treatment of obesity, or surgery to remove a segment of&#xD;
                  the GI tract at any time before the Screening Visit (Visit 1).&#xD;
&#xD;
               -  b) Surgery of the abdomen, pelvis, or retroperitoneal structures during the 6&#xD;
                  months before the Screening Visit (Visit 1)&#xD;
&#xD;
               -  c) An appendectomy or cholecystectomy during the 60 days before the Screening&#xD;
                  Visit&#xD;
&#xD;
               -  d) Other major surgery during the 30 days before the Screening Visit (Visit 1)&#xD;
&#xD;
          -  Participant is receiving enteral tube feeding&#xD;
&#xD;
          -  Participants who have positive urine drug screen results for cocaine, barbiturates,&#xD;
             opiates, or cannabinoids will be excluded from study participation.&#xD;
&#xD;
        Exclusion Criteria for LIN-MD-62, LIN-MD-63 and LIN-MD-64 Completers Who Enroll in&#xD;
        LIN-MD-66 &gt; 28 Days From Last Study Intervention:&#xD;
&#xD;
          -  Participant has a history of nonretentive fecal incontinence&#xD;
&#xD;
          -  For LIN-MD-62 and LIN-MD-64 completers only:&#xD;
&#xD;
        Participant meets Rome III criteria for child/adolescent IBS: at least once per week for at&#xD;
        least 2 months before Screening (Visit 1), the participant has experienced abdominal&#xD;
        discomfort (an uncomfortable sensation not described as pain) or pain associated with 2 or&#xD;
        more of the following at least 25% of the time:&#xD;
&#xD;
          -  a) Improvement with defecation&#xD;
&#xD;
          -  b) Onset associated with a change in the frequency of stool&#xD;
&#xD;
          -  c) Onset associated with a change in form (appearance) of stool&#xD;
&#xD;
               -  Participant has a history of drug or alcohol abuse&#xD;
&#xD;
               -  Participant has any of the following conditions:&#xD;
&#xD;
          -  a) Celiac disease, or positive serological test for celiac disease and the condition&#xD;
             has not been ruled out by endoscopic biopsy&#xD;
&#xD;
          -  b) Cystic fibrosis&#xD;
&#xD;
          -  c) Hypothyroidism that is untreated or treated with thyroid hormone at a dose that has&#xD;
             not been stable for at least 3 months prior to the Screening (Visit 1)&#xD;
&#xD;
          -  d) Lead toxicity, hypercalcemia&#xD;
&#xD;
          -  e) Inflammatory bowel disease&#xD;
&#xD;
          -  f) Childhood functional abdominal pain syndrome&#xD;
&#xD;
          -  g) Childhood functional abdominal pain&#xD;
&#xD;
          -  h) Poorly treated or poorly controlled psychiatric disorders that might influence his&#xD;
             or her ability to participate in the study&#xD;
&#xD;
          -  i) Lactose intolerance that is associated with abdominal pain or discomfort and could&#xD;
             confound the assessments in this study&#xD;
&#xD;
          -  j) History of cancer other than treated basal cell carcinoma of the skin. (Note:&#xD;
             Participants with a history of cancer are allowed provided that the malignancy has&#xD;
             been in a complete remission for at least 5 years before the Randomization Visit. A&#xD;
             complete remission is defined as the disappearance of all signs of cancer in response&#xD;
             to treatment.)&#xD;
&#xD;
          -  k) History of diabetic neuropathy&#xD;
&#xD;
               -  Participants who have positive urine drug screen results for cocaine,&#xD;
                  barbiturates, opiates, or cannabinoids.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ALLERGAN INC.</last_name>
    <role>Study Director</role>
    <affiliation>Allergan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Research Associates /ID# 237953</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G &amp; L Research, LLC /ID# 238093</name>
      <address>
        <city>Foley</city>
        <state>Alabama</state>
        <zip>36535</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Clinical Trials Inc. /ID# 234605</name>
      <address>
        <city>Saraland</city>
        <state>Alabama</state>
        <zip>36571</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthStar Research of Hot Springs PLLC /ID# 234608</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Preferred Research Partners /ID# 237109</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Applied Research Center of Arkansas /ID# 238069</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72212-4187</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Research Center /ID# 237960</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance Research Institute /ID# 234604</name>
      <address>
        <city>Bell Gardens</city>
        <state>California</state>
        <zip>90201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kindred Medical Institute, LLC /ID# 237367</name>
      <address>
        <city>Corona</city>
        <state>California</state>
        <zip>92879</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance Research Institute Llc /Id# 234283</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>91303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Trials LLC /ID# 234629</name>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <zip>90723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Ctr for Clin Research /ID# 236911</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paragon Rx Clinical Inc /ID# 234602</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lynn Institute of Denver /ID# 238086</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado /ID# 239185</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center /ID# 234417</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010-2916</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prohealth Research Center /ID# 234659</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dolphin Medical Research /ID# 234676</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33172</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amedica Research Institute Inc /ID# 234666</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duplicate_Nemours Childrens Specialty Care /ID# 237991</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elite Clinical Research /ID# 234651</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Biotech Pharmaceutical Group /ID# 237943</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Miami Medical &amp; Research Group Inc. /ID# 234654</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valencia Medical &amp; Research Center /ID# 234671</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Research for Health Improvement /ID# 238253</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34102-5430</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric &amp; Adult Research Center /ID# 234681</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Hospital /ID# 234429</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827-7884</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oviedo Medical Research /ID# 234692</name>
      <address>
        <city>Oviedo</city>
        <state>Florida</state>
        <zip>32765</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Treken Primary Care /ID# 234645</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30315</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta - Ferry Rd /ID# 237005</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342-1605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Ctr Digestive, US /ID# 237574</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>River Birch Research Alliance /ID# 237963</name>
      <address>
        <city>Blue Ridge</city>
        <state>Georgia</state>
        <zip>30513</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute /ID# 234702</name>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Care Research Institute d/b/a Clinical Research Institute /ID# 236342</name>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials Specialist Inc /ID# 234652</name>
      <address>
        <city>Stone Mountain</city>
        <state>Georgia</state>
        <zip>30083</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rophe Adult and Pediatric Medicine/SKYCRNG /ID# 234650</name>
      <address>
        <city>Union City</city>
        <state>Georgia</state>
        <zip>30291</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance for Multispecialty Research LLC /ID# 234502</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KU Wichita Center for Clinical Research /ID# 234500</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael W. Simon, MD, PSC /ID# 236516</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40517</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virgo Carter Pediatrics /ID# 234518</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Childrens Hospital /ID# 237567</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MNGI Digestive Health, P. A. /ID# 234437</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55413-2195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GI associates and Endoscopy Ce /ID# 237969</name>
      <address>
        <city>Flowood</city>
        <state>Mississippi</state>
        <zip>39232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David M. Headley, MD, P.A. /ID# 238216</name>
      <address>
        <city>Port Gibson</city>
        <state>Mississippi</state>
        <zip>39150-2024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice - Dr. Craig Spiegel /ID# 234545</name>
      <address>
        <city>Bridgeton</city>
        <state>Missouri</state>
        <zip>63044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medclinical Research Partners LLC/ Foundation Pediatrics /ID# 234566</name>
      <address>
        <city>East Orange</city>
        <state>New Jersey</state>
        <zip>07018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of New Mexico /ID# 236983</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102-4517</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Biomedical Research Alliance of NY-Montefiore Medical Center /ID# 235139</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advantage Clinical Trials /ID# 237932</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center and Morgan Stanley Children's Hospital of NY /ID# 235686</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Carolina University Brody School of Medicine /ID# 237509</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Piedmont Healthcare-Statesville /ID# 238257</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ Oklahoma HSC /ID# 237546</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IPS Research Company /ID# 237669</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frontier Clinical Research, LLC - Scottdale /ID# 238022</name>
      <address>
        <city>Scottdale</city>
        <state>Pennsylvania</state>
        <zip>15683</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frontier Clinical Research /ID# 237923</name>
      <address>
        <city>Smithfield</city>
        <state>Pennsylvania</state>
        <zip>15478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital /ID# 237861</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatric Research - West Ashley B /ID# 234678</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatric Research - Summerville /ID# 234674</name>
      <address>
        <city>Summerville</city>
        <state>South Carolina</state>
        <zip>29486</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Jackson Clinic, PA /ID# 236772</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Accellacare of Knoxville /ID# 234462</name>
      <address>
        <city>Jefferson City</city>
        <state>Tennessee</state>
        <zip>37760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Children's Hospital /ID# 234457</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cook Children's Med. Center /ID# 237536</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Institute of Research /ID# 234475</name>
      <address>
        <city>Harlingen</city>
        <state>Texas</state>
        <zip>78550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilo Research Group Inc /ID# 238228</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77017-2337</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cullen Research /ID# 234482</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77051</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pioneer Research Solutions, Inc. /ID# 236935</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77098-5294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AIM Trials /ID# 236364</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Research Institute /ID# 236932</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ClinPoint Trials /ID# 236615</name>
      <address>
        <city>Waxahachie</city>
        <state>Texas</state>
        <zip>75165-1430</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chrysalis Clinical Research /ID# 234515</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Maria Ona /ID# 234539</name>
      <address>
        <city>Franklin</city>
        <state>Virginia</state>
        <zip>23851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Research of Hampton Roads, Inc. (HRHR) /ID# 237252</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Partners, LLC /ID# 237158</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23220-4459</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carilion Medical Center /ID# 236873</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multicare Institute for Research and Innovation /ID# 236979</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshall University Medical Center /ID# 236567</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25701-3656</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin - Plank Rd /ID# 234392</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226-3548</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Gent /ID# 237589</name>
      <address>
        <city>Gent</city>
        <state>Oost-Vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Brussel /ID# 234746</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KU Leuven /ID# 234766</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Plovdiv /ID# 234621</name>
      <address>
        <city>Tsentar</city>
        <state>Plovdiv</state>
        <zip>4001</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHATSv.Ivan Rilski /ID# 234695</name>
      <address>
        <city>Kozloduy</city>
        <zip>3320</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT Kanev /ID# 237807</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical center 1 Sevlievo /ID# 237469</name>
      <address>
        <city>Sevlievo</city>
        <zip>5400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical center 1 Sevlievo /ID# 237472</name>
      <address>
        <city>Sevlievo</city>
        <zip>5400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital - Division of Hematology /ID# 238197</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Center /ID# 234309</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SKDS Research Inc. /ID# 236874</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bluewater Clinical Research Group Inc /ID# 234618</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <zip>N7T 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stouffville Medical Centre /ID# 234619</name>
      <address>
        <city>Stouffville</city>
        <state>Ontario</state>
        <zip>L4A 1H2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Al Mare Perearstikeskus /ID# 234753</name>
      <address>
        <city>Harjumaa</city>
        <zip>10617</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Merelahe Family Doctors Centre /ID# 234756</name>
      <address>
        <city>Tallinn</city>
        <zip>10617</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliiniliste Uuringute Keskus /ID# 234759</name>
      <address>
        <city>Tartu</city>
        <zip>50410</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Leipzig /ID# 237258</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel /ID# 237174</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soproni Erzsebet Oktato Korhaz es Rehabilitacios Intezet /ID# 237340</name>
      <address>
        <city>Sopron</city>
        <zip>9400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center /ID# 236760</name>
      <address>
        <city>Ramat Gan</city>
        <state>Tel-Aviv</state>
        <zip>5239424</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus Ruth Rappaport Children's Hospital /ID# 234771</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Edith Wolfson Medical Center /ID# 237195</name>
      <address>
        <city>Holon</city>
        <zip>5822000</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center /ID# 237713</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Hebrew University Hospital - Ein Kerem /ID# 234735</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Baruch Padeh Medical Center Poriya /ID# 234768</name>
      <address>
        <city>Lower Galilee</city>
        <zip>15208</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schneider Children's Medical Center /ID# 237520</name>
      <address>
        <city>Petah Tikva</city>
        <zip>4920235</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale Pediatrico Bambino Gesu /ID# 238183</name>
      <address>
        <city>Rome</city>
        <state>Lazio</state>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sant�Andrea University Hospital /ID# 234688</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum /ID# 237116</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maasstad Ziekenhuis /ID# 236900</name>
      <address>
        <city>Rotterdam</city>
        <zip>3079 DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala /ID# 237221</name>
      <address>
        <city>Zwolle</city>
        <zip>8025 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gabinet Lekarski Bartosz Korcz /ID# 237356</name>
      <address>
        <city>Rzeszow</city>
        <state>Podkarpackie</state>
        <zip>35-210</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Poradnia Gastroenterologiczna dla Dzieci /ID# 234709</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-094</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Pediatrii Gastroenterologii Alergologii i Zywienia Dzieci GUM /ID# 234713</name>
      <address>
        <city>Gdansk</city>
        <zip>80-803</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Poradnia Gastroenterologiczna /ID# 234711</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-561</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital 'Tirsova' /ID# 238309</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital /ID# 234764</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Child and Youth Health Care of Vojvodina /ID# 234761</name>
      <address>
        <city>Novi Sad</city>
        <zip>21000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario de Malaga /ID# 234641</name>
      <address>
        <city>Malaga</city>
        <zip>29011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Hispalense Pediatria /ID# 234643</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Communal Nonprofit Enterprise Chernivtsi Regional Childrens Clinical /ID# 234732</name>
      <address>
        <city>Chernivtsi</city>
        <zip>58023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Communal Nonprofit Enterprise City Childrens Clinical Hospital 6 of Dnipro C /ID# 234734</name>
      <address>
        <city>Dnipro</city>
        <zip>49064</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vinnytsya National Medical University /ID# 235680</name>
      <address>
        <city>Iuilia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kharkiv Regional Childrens Clinical Hospital Gastroent. Centre Kharkiv Natl. Me /ID# 234739</name>
      <address>
        <city>Kharkiv</city>
        <zip>61093</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Nonprofit Enterprise Lviv City Children's Clinical Hospital /ID# 234723</name>
      <address>
        <city>Lviv</city>
        <zip>79059</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Harvey Hospital /ID# 234660</name>
      <address>
        <city>Ashford</city>
        <state>Kent</state>
        <zip>TN24 0LZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester University NHS Foundation Trust /ID# 234664</name>
      <address>
        <city>Manchester</city>
        <state>Lancashire</state>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barts Health NHS Trust /ID# 237607</name>
      <address>
        <city>London</city>
        <state>London, City Of</state>
        <zip>E1 2ES</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Women's and Children's NHS Foundation Trust /ID# 236781</name>
      <address>
        <city>Birmingham</city>
        <zip>B4 6NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital NHS Foundation Trusts /ID# 236304</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Estonia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.AllerganClinicalTrials.com</url>
    <description>Additional information on study locations near you may be found at AllerganClinicalTrials.com.</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 11, 2019</study_first_submitted>
  <study_first_submitted_qc>November 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>AbbVie is committed to responsible data sharing regarding the clinical trials we sponsor. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information (e.g., protocols and clinical study reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>For details on when studies are available for sharing, please refer to the link below</ipd_time_frame>
    <ipd_access_criteria>Access to this clinical trial data can be requested by any qualified researchers who engage in rigorous, independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Use Agreement (DUA). For more information on the process, or to submit a request, visit the following link.</ipd_access_criteria>
    <ipd_url>https://vivli.org/ourmember/abbvie/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

